These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743 [TBL] [Abstract][Full Text] [Related]
7. The role of autoantibodies in Lambert-Eaton myasthenic syndrome. Lang B; Waterman S; Pinto A; Jones D; Moss F; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Motomura M; Moll JW; Vincent A; Newsom-Davis J Ann N Y Acad Sci; 1998 May; 841():596-605. PubMed ID: 9668304 [No Abstract] [Full Text] [Related]
9. Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome? Fletcher CF; Lennon VA Ann Neurol; 2003 Jan; 53(1):5-7. PubMed ID: 12509841 [No Abstract] [Full Text] [Related]
10. SOX1 autoantibodies: tumor markers in LEMS patients? Lang B; Evoli A Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313 [No Abstract] [Full Text] [Related]
12. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Leys K; Lang B; Johnston I; Newsom-Davis J Ann Neurol; 1991 Mar; 29(3):307-14. PubMed ID: 1645944 [TBL] [Abstract][Full Text] [Related]
13. Absence of anti-P/Q calcium channel antibody in the sera of patients with anti-Yo antibody-positive paraneoplastic cerebellar degeneration. Tanaka K; Motomura M; Nakao Y; Tanaka M; Tsuji S Neurology; 1997 Sep; 49(3):895-6. PubMed ID: 9305368 [No Abstract] [Full Text] [Related]
14. A case report of the efficient reduction of calcium channel antibodies by tryptophan ligand immunoadsorption in a patient with Lambert-Eaton syndrome. Sauter M; Bender A; Heller F; Sitter T Ther Apher Dial; 2010 Jun; 14(3):364-7. PubMed ID: 20609193 [TBL] [Abstract][Full Text] [Related]
15. Specificity of autoantibodies react with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome. Suenaga A; Shirabe S; Nakamura T; Motomura M; Tsujihata M; Matsuo H; Kataoka Y; Niwa M; Itoh M; Nagataki S Muscle Nerve; 1996 Sep; 19(9):1166-8. PubMed ID: 8761275 [No Abstract] [Full Text] [Related]
16. Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome. Hermitte L; Martin-Moutot N; Boucraut J; Barone R; Atlan-Gepner C; Seagar M; Pouget J; Kleisbauer JP; Couraud F; Vialettes B J Clin Immunol; 2000 Jul; 20(4):287-93. PubMed ID: 10939716 [TBL] [Abstract][Full Text] [Related]
17. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Vincent A; Lang B; Newsom-Davis J Trends Neurosci; 1989 Dec; 12(12):496-502. PubMed ID: 2480664 [TBL] [Abstract][Full Text] [Related]
18. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome]. Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958 [TBL] [Abstract][Full Text] [Related]
19. Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome. Martin-Moutot N; Haro Ld; Santos RG; Mori Y; Seagar M Neurobiol Dis; 2006 Apr; 22(1):57-63. PubMed ID: 16289869 [TBL] [Abstract][Full Text] [Related]
20. Coexistence of paraneoplastic sensory neuronopathy and Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient. Kawahara M; Furuse K; Kodama N; Ogawara M; Kubota K; Yamamoto S; Tada H; Mori T; Miyawaki Y; Hirohashi S Jpn J Clin Oncol; 1994 Aug; 24(4):224-7. PubMed ID: 8072202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]